drugset / Trial / NCT00974662
Study Using WST11 in Patients With Obstructing Endobronchial Non-Small Cell Lung Cancer
NaSingle-groupOpen-labelTreatment
Summary
The aim of this study is to determine the dose of WST11 and light energy necessary to obtain desobstruction of the bronchial lumen using Vascular Targeted Photodynamic therapy in obstructive Non-Small Cell Lung Cancer.
Timeline
- Start
- 2009-09
- Primary completion
- 2010-11
- Completion
- 2011-12
Outcome
Outcome not reported
Stopped: “Early end of enrolment with regards to difficulty met to enrol patients.”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Padeliporfin | Other / unclassified | 5 mg/kg | Intravenous |
| Subject | Padeliporfin | Other / unclassified | 7.5 mg/kg | Intravenous |
| Subject | Padeliporfin | Other / unclassified | 10 mg/kg | Intravenous |